Loading...

LYRA LYRA THERAPEUTICS INC Business Restructuring 8-K Filing

LYR

LYR

LYRA THERAPEUTICS INC

(LYRA)

2024 8-K

Show Summary

Show Summary

Investor Meetings

Reverse Stock Split

Financial Statements

Financial Results

Corporate Presentation

Financial Results

Financial Results

Delisting Notice

Amendment Approval at Annua...

Workforce Reduction Costs

Workforce Reduction

Financial Results Announcement

Management Changes

Financial Results Announcement

Salary Increase

Corporate Presentation

Sublease Agreement

Bylaws Amendments

Financial Results Announcement

Slide Presentation

Equity Offering

Financial Results Announcement

Annual Meeting of Stockholders

Private Placement

Financial Results Announcement

Financial Results Announcement

External Links:

Lyra Therapeutics, Inc. filed an amendment to their previous report to disclose the estimated costs associated with a workforce reduction, which is expected to incur charges of approximately $3.9 to $4.1 million primarily consisting of severance paym

AI Assistant

LYRA THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.